A new dengue vaccine should only be used in people who were previously infected, WHO says

The World Health Organization (WHO) in Geneva, Switzerland, put the brakes on implementation of the world’s first dengue vaccine today when it recommended it only be used in people who have previously been infected with the disease—a move that will shrink the potential market for the vaccine’s producer, Sanofi Pasteur. Read more.

WHO_16x9[2]

Author: Dr. Baek

- Scientist (Microbiology, Synthetic Biology, Molecular Biology). - Founder / CEO of the biotech company Peption LLC. - Passionate about biotechnological innovations to address important global health issues.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s